The Effect of Non-Surgical Periodontal Therapy on Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 1, 2024

Study Completion Date

October 1, 2024

Conditions
PeriodontitisInflammatory Bowel Diseases
Interventions
OTHER

ELISA (Enzyme-Linked ImmunoSorbent Assay)

A total of 60 individuals, 15 with IBD and periodontitis, 15 with IBD and periodontal health, 15 with systemic health and periodontitis, and 15 with systemic and periodontal health, will be included in the study. At the beginning of the study, periodontal clinical measurements (gingival index, plaque index, probing depth, gingival recession, clinical attachment level, bleeding on probing) and serum, saliva and gingival samples will be obtained from all individuals. Individuals with periodontitis will receive non-surgical periodontal treatment in half jaws within 2 weeks. Clinical measurements, serum and saliva sample collection will be repeated 3 months after the treatment. Biomarker levels in serum and saliva samples will be analysed by ELISA.

Trial Locations (1)

34025

Biruni University, Istanbul

All Listed Sponsors
lead

Biruni University

OTHER

NCT06245278 - The Effect of Non-Surgical Periodontal Therapy on Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter